Healthcare · Biotechnology
Price
$14.80
Market Cap
$160.7M
Employees
121
Beta
0.15
Avg Volume
95,524
CEO
Ofer Gonen
Business Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Business History
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-7.05
Stock Price: $14.80
EPS (Diluted): -2.10
EPS (Diluted): -2.10
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
4.81
Stock Price: $14.80
Total Equity: $43.63M
Shares: 11,376,571
Total Equity: $43.63M
Shares: 11,376,571
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-8.66
Market Cap: $160.71M
Total Debt: $623,000
Cash: $4.80M
EBITDA: -$21.47M
Total Debt: $623,000
Cash: $4.80M
EBITDA: -$21.47M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$213.4M
Market Cap: $160.71M
Total Debt: $623,000
Cash: $4.80M
Total Debt: $623,000
Cash: $4.80M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
12.38
Stock Price: $14.80
Revenue: $16.96M
Shares: 11,376,571
Revenue: $16.96M
Shares: 11,376,571
EV/Sales (Total value vs revenue — works when P/E can't)
API12.58
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
19.2%
Gross Profit: $3.25M
Revenue: $16.96M
Revenue: $16.96M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-149.1%
Operating Income: -$25.28M
Revenue: $16.96M
Revenue: $16.96M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-140.8%
Net Income: -$23.88M
Revenue: $16.96M
Revenue: $16.96M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-67.2%
Net Income: -$23.88M
Total Equity: $43.63M
Total Equity: $43.63M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-47.3%
Operating Income: -$25.28M
Tax Rate: -0.7%
Equity: $43.63M
Total Debt: $623,000
Cash: $4.80M
Tax Rate: -0.7%
Equity: $43.63M
Total Debt: $623,000
Cash: $4.80M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
2.33
Current Assets: $59.96M
Current Liabilities: $25.71M
Current Liabilities: $25.71M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.01
Short-Term Debt: $623,000
Long-Term Debt: $0.00
Total Debt: $623,000
Total Equity: $43.63M
Long-Term Debt: $0.00
Total Debt: $623,000
Total Equity: $43.63M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$1.49
Revenue: $16.96M
Shares: 11,376,571
Shares: 11,376,571
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$3.84
Total Equity: $43.63M
Shares: 11,376,571
Shares: 11,376,571
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-1.76
Operating CF: -$14.53M
CapEx: -$5.51M
Shares: 11,376,571
CapEx: -$5.51M
Shares: 11,376,571
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $14.80
Stock Price: $14.80
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$23.88M
Net Income: -$23.88M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares MDWD against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 24, 2026 12:01pm (2d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $23.8M | $26.5M | $18.7M | $20.2M | $17.0M |
| Cost of Revenue | $15.0M | $13.3M | $15.1M | $17.6M | $13.7M |
| Gross Profit | $8.8M | $13.2M | $3.6M | $2.6M | $3.3M |
| Operating Expenses | $20.0M | $20.8M | $19.1M | $22.0M | $28.5M |
| Operating Income | -$11.2M | -$7.7M | -$15.5M | -$19.4M | -$25.3M |
| Net Income | -$13.6M | -$19.6M | -$6.7M | -$30.2M | -$23.9M |
| EBITDA | -$11.4M | -$18.2M | -$4.8M | -$27.9M | -$21.5M |
| EPS | $-3.48 | $-3.93 | $-0.75 | $-3.03 | $-2.10 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 24, 2026 12:01pm (2d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $11.0M | $33.9M | $11.9M | $9.2M | $4.8M |
| Total Current Assets | $15.0M | $45.8M | $49.7M | $52.2M | $60.0M |
| Total Assets | $19.7M | $50.0M | $66.5M | $73.5M | $86.3M |
| Current Liabilities | $10.7M | $12.1M | $10.8M | $26.5M | $25.7M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $24.3M | $39.1M | $34.9M | $42.3M | $34.3M |
| Total Equity | -$4.6M | $10.9M | $31.6M | $31.2M | $43.6M |
| Retained Earnings | -$148.5M | -$168.1M | -$174.8M | -$205.0M | -$228.9M |
Cash Flow (Annual)
Last updated: Jun 24, 2026 12:01pm (2d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$8.9M | -$11.9M | -$10.5M | -$13.6M | -$14.5M |
| Capital Expenditure | $-489,000 | $-555,000 | -$6.5M | -$6.3M | -$5.5M |
| Free Cash Flow | -$9.4M | -$12.4M | -$16.9M | -$19.9M | -$20.0M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$6.3M | $22.8M | -$22.0M | -$2.7M | -$4.4M |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 2:33pm (18h ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$32.9M $31.8M – $34.1M
|
$50.1M $50.1M – $50.1M
|
$108.7M $103.5M – $113.4M
|
$168.4M $160.5M – $175.7M
|
| EBITDA |
-$22.5M -$23.4M – -$21.8M
|
-$34.3M -$34.3M – -$34.3M
|
-$74.4M -$77.6M – -$70.9M
|
-$115.4M -$120.3M – -$109.9M
|
| Net Income |
-$24.4M -$29.7M – -$19.1M
|
-$13.8M -$17.1M – -$10.6M
|
$7.1M $6.6M – $7.4M
|
$27.2M $25.5M – $28.7M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 24, 2026 12:01pm (2d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +11.5% | -29.5% | +8.2% | -16.1% |
| Gross Profit Growth | +50.1% | -72.8% | -26.4% | +23.5% |
| Operating Income Growth | +31.7% | -102.3% | -25.0% | -30.4% |
| Net Income Growth | -44.6% | +65.7% | -350.0% | +21.0% |
| EBITDA Growth | -60.3% | +73.7% | -481.7% | +23.1% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 8:01am (56m ago)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-03 | SHAMIR NACHUM | P-Purchase | 5,825.00 | $14.00 | $81,550 |
| 2026-06-03 | SHAMIR NACHUM | P-Purchase | 175.00 | $13.98 | $2,446 |
| 2026-06-01 | Fox David Morton | P-Purchase | 1,797.00 | $14.00 | $25,149 |
| 2026-06-01 | Fox David Morton | P-Purchase | 10.00 | $14.23 | $142 |
| 2026-06-01 | Fox David Morton | P-Purchase | 1,730.00 | $14.23 | $24,609 |
| 2026-05-29 | Rubinstein Samuel | P-Purchase | 150.00 | $14.33 | $2,150 |
| 2026-03-18 | Driver Vickie Rae | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Driver Vickie Rae | 0.00 | $0.00 | $0 | |
| 2021-06-29 | Driver Vickie Rae | 14,285.00 | $12.25 | $174,991 | |
| 2022-06-15 | Driver Vickie Rae | 1,607.00 | $37.52 | $60,295 | |
| 2023-05-16 | Driver Vickie Rae | 5,357.00 | $14.42 | $77,248 | |
| 2024-05-31 | Driver Vickie Rae | 5,900.00 | $11.89 | $70,122 | |
| 2025-02-26 | Driver Vickie Rae | 7,542.00 | $12.73 | $96,002 | |
| 2026-02-11 | Driver Vickie Rae | 5,600.00 | $18.54 | $103,824 | |
| 2026-03-18 | Driver Vickie Rae | 6,250.00 | $17.60 | $110,000 | |
| 2026-03-18 | Luxenburg Kalfon Hana | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Luxenburg Kalfon Hana | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Luxenburg Kalfon Hana | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Luxenburg Kalfon Hana | 39,000.00 | $11.90 | $464,100 | |
| 2026-03-18 | Luxenburg Kalfon Hana | 32,681.00 | $12.73 | $415,996 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for MDWD — it's generated by the pipeline (
market-narrative step).
No community reviews yet for MDWD.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30